Table 1.

Animal and treatment group information for in vivo expansion trial

	Animal ID	Age (yrs)	Weight (kg)	Antigen	rhIL-2
Group 1	NM11	16	18.6	Zoledronic acid monohydrate (0.2 mg/kg IV)	0.8x106 IU SC, q24 h for 5 days
	NM89	14	21.1
Group 2	NM88	14	13.6	Zoledronic acid monohydrate (0.5 mg, IT)
	NM283	7	11.1
Group 3	NM251	9	13.8	HMB-PP (1 mg/kg IV + 0.25 mg IT)
	NM295	7	8.6
Group 4	NM269	8	12.0	IPP (0.5 mg IT)